AREV Life Sciences Global AREVF Stock
AREV Life Sciences Global Price Chart
AREV Life Sciences Global AREVF Financial and Trading Overview
AREV Life Sciences Global stock price | 0.0100 USD |
Previous Close | 0.1 USD |
Open | 0.1 USD |
Bid | N/A x N/A |
Ask | N/A x N/A |
Day's Range | 0.1 - 0.1 USD |
52 Week Range | 0.05 - 0.21 USD |
Volume | 333 USD |
Avg. Volume | 164 USD |
Market Cap | 4.02M USD |
Beta (5Y Monthly) | 2.840788 |
PE Ratio (TTM) | N/A |
EPS (TTM) | -0.01 USD |
Forward Dividend & Yield | N/A (N/A) |
Ex-Dividend Date | N/A |
1y Target Est | N/A |
AREVF Valuation Measures
Enterprise Value | 3.33M USD |
Trailing P/E | N/A |
Forward P/E | N/A |
PEG Ratio (5 yr expected) | N/A |
Price/Sales (ttm) | 21.858713 |
Price/Book (mrq) | N/A |
Enterprise Value/Revenue | 18.099 |
Enterprise Value/EBITDA | -2.017 |
Trading Information
AREV Life Sciences Global Stock Price History
Beta (5Y Monthly) | 2.840788 |
52-Week Change | 16.12% |
S&P500 52-Week Change | 20.43% |
52 Week High | 0.21 USD |
52 Week Low | 0.05 USD |
50-Day Moving Average | 0.12 USD |
200-Day Moving Average | 0.13 USD |
AREVF Share Statistics
Avg. Volume (3 month) | 164 USD |
Avg. Daily Volume (10-Days) | 0 USD |
Shares Outstanding | 31.54M |
Float | 16.86M |
Short Ratio | N/A |
% Held by Insiders | 14.10% |
% Held by Institutions | 0% |
Shares Short | N/A |
Short % of Float | N/A |
Short % of Shares Outstanding | N/A |
Dividends & Splits
Trailing Annual Dividend Rate | 0 |
Trailing Annual Dividend Yield | 0% |
5 Year Average Dividend Yield | N/A |
Payout Ratio | 0 |
Last Split Factor | 1:6 |
Financial Highlights
Fiscal Year
Fiscal Year Ends | December 31, 2021 |
Most Recent Quarter (mrq) | September 30, 2022 |
Next Fiscal Year End | December 31, 2022 |
Profitability
Profit Margin | 0% |
Operating Margin (ttm) | -923.93% |
Gross Margin | 91.48% |
EBITDA Margin | 0% |
Management Effectiveness
Return on Assets (ttm) | -264.13% |
Return on Equity (ttm) | N/A |
Income Statement
Revenue (ttm) | 183.89K USD |
Revenue Per Share (ttm) | 0.008 USD |
Quarterly Revenue Growth (yoy) | -12.80% |
Gross Profit (ttm) | N/A |
EBITDA | -1649800 USD |
Net Income Avi to Common (ttm) | -1022069 USD |
Diluted EPS (ttm) | -0.03 |
Quarterly Earnings Growth (yoy) | N/A |
Balance Sheet
Total Cash (mrq) | 15.17K USD |
Total Cash Per Share (mrq) | 0 USD |
Total Debt (mrq) | 50.89K USD |
Total Debt/Equity (mrq) | N/A |
Current Ratio (mrq) | 0.111 |
Book Value Per Share (mrq) | -0.027 |
Cash Flow Statement
Operating Cash Flow (ttm) | -375695 USD |
Levered Free Cash Flow (ttm) | -121026 USD |
Profile of AREV Life Sciences Global
Country | United States |
State | BC |
City | Coquitlam |
Address | 18 - 91 Golden Drive |
ZIP | V3K 6R2 |
Phone | 604 803 8439 |
Website | https://www.arevlifesciences.com |
Industry | Drug Manufacturers-Specialty & Generic |
Sector(s) | Healthcare |
Full Time Employees | N/A |
AREV Life Sciences Global Corp., an integrated life science discovery company, produces and sells functional ingredients in Canada. The company's CBD-infused products, include Canna-Mulsion and NaturVax, anti- viral supplements; NaturRelax, a natural Sleep Aid; Natur Relief, an anti-inflator and pain relief product; and white label cannabis products, as well as a range of THC products, and cannabis skincare products and medicinal oils and edibles. Its ingredients are used in products that are targeted for sale in the natural health, medical, functional food, nutraceutical, sports nutrition, and bioceutical markets. In addition, the company's products address the areas of health, which include sleep deprivation, insomnia, anxiety, pain, and inflammatory conditions, as well as other specific ailments. Further, it offers nutraceutical product formulations under the Bare brand name; and ready-to-use therapeutic food products under the SUS-TAINN name. The company was formerly known as AREV NanoTec Brands Inc. and changed its name to AREV Life Sciences Global Corp. in August 2021. AREV Life Sciences Global Corp. was incorporated in 2005 and is based in Coquitlam, Canada.
Q&A For AREV Life Sciences Global Stock
What is a current AREVF stock price?
AREV Life Sciences Global AREVF stock price today per share is 0.0100 USD.
How to purchase AREV Life Sciences Global stock?
You can buy AREVF shares on the OTC Markets EXMKT exchange. Contact your financial advisor to select a broker.
What is the ticker symbol for AREV Life Sciences Global?
The stock symbol or ticker of AREV Life Sciences Global is AREVF.
Which industry does the AREV Life Sciences Global company belong to?
The AREV Life Sciences Global industry is Drug Manufacturers-Specialty & Generic.
How many shares does AREV Life Sciences Global have in circulation?
The max supply of AREV Life Sciences Global shares is 31.76M.
What is AREV Life Sciences Global Price to Earnings Ratio (PE Ratio)?
AREV Life Sciences Global PE Ratio is now.
What was AREV Life Sciences Global earnings per share over the trailing 12 months (TTM)?
AREV Life Sciences Global EPS is -0.01 USD over the trailing 12 months.
Which sector does the AREV Life Sciences Global company belong to?
The AREV Life Sciences Global sector is Healthcare.